These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 16706475)

  • 1. Investigations into the analysis and modeling of the cytochrome P450 cycle.
    Wang Y; Li Y; Li Y; Ma X; Yang S; Yang L
    J Phys Chem B; 2006 May; 110(20):10139-43. PubMed ID: 16706475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stochastic simulations of the cytochrome P450 catalytic cycle.
    Wang Y; Li Y; Wang B
    J Phys Chem B; 2007 Apr; 111(16):4251-60. PubMed ID: 17402779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characteristics of purified beef liver NADPH-cytochrome P450 reductase.
    Arinç E; Celik H
    J Biochem Mol Toxicol; 2002; 16(6):286-97. PubMed ID: 12481304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of cytochrome b5 by NADPH-cytochrome P450 reductase.
    Guengerich FP
    Arch Biochem Biophys; 2005 Aug; 440(2):204-11. PubMed ID: 16055078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites.
    Avent KM; DeVoss JJ; Gillam EM
    Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rate-limiting steps in cytochrome P450 catalysis.
    Guengerich FP
    Biol Chem; 2002 Oct; 383(10):1553-64. PubMed ID: 12452431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First evidence that cytochrome P450 may catalyze both S-oxidation and epoxidation of thiophene derivatives.
    Dansette PM; Bertho G; Mansuy D
    Biochem Biophys Res Commun; 2005 Dec; 338(1):450-5. PubMed ID: 16137656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
    Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
    Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
    Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
    J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory evolution of P450 BM3 for mediated electron transfer yielding an activity-improved and reductase-independent variant.
    Nazor J; Dannenmann S; Adjei RO; Fordjour YB; Ghampson IT; Blanusa M; Roccatano D; Schwaneberg U
    Protein Eng Des Sel; 2008 Jan; 21(1):29-35. PubMed ID: 18093991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochromes P450 reconstituted with NADPH: P450 reductase mimic the activating and detoxicating metabolism of the anticancer drug ellipticine in microsomes.
    Kotrbová V; Aimová D; Brezinová A; Janouchová K; Poljaková J; Frei E; Stiborová M
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():18-22. PubMed ID: 17159771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of perinatal low protein diets on the ontogeny of select hepatic cytochrome p450 enzymes and cytochrome p450 reductase in the rat.
    Cherala G; Shapiro BH; D'mello AP
    Drug Metab Dispos; 2007 Jul; 35(7):1057-63. PubMed ID: 17392395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical and experimental studies of the conversion of chromopyrrolic acid to an antitumor derivative by cytochrome P450 StaP: the catalytic role of water molecules.
    Wang Y; Chen H; Makino M; Shiro Y; Nagano S; Asamizu S; Onaka H; Shaik S
    J Am Chem Soc; 2009 May; 131(19):6748-62. PubMed ID: 19385626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient bioelectronic actuation of the natural catalytic pathway of human metabolic cytochrome P450s.
    Krishnan S; Wasalathanthri D; Zhao L; Schenkman JB; Rusling JF
    J Am Chem Soc; 2011 Feb; 133(5):1459-65. PubMed ID: 21214177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 3A, NADPH cytochrome P450 reductase and cytochrome b5 in the upper airways in horse.
    Tydén E; Olsén L; Tallkvist J; Tjälve H; Larsson P
    Res Vet Sci; 2008 Aug; 85(1):80-5. PubMed ID: 17980394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly active single-mutation variant of P450BM3 (CYP102A1).
    Whitehouse CJ; Bell SG; Yang W; Yorke JA; Blanford CF; Strong AJ; Morse EJ; Bartlam M; Rao Z; Wong LL
    Chembiochem; 2009 Jul; 10(10):1654-6. PubMed ID: 19492389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving catalytic properties of P450 BM3 haem domain electrodes by molecular Lego.
    Fantuzzi A; Meharenna YT; Briscoe PB; Sassone C; Borgia B; Gilardi G
    Chem Commun (Camb); 2006 Mar; (12):1289-91. PubMed ID: 16538250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenomenon of activation of cytochrome P450 by nonionic detergents.
    Myasoedova KN; Arutyunyan AM; Magretova NN
    Biosci Rep; 2006 Feb; 26(1):69-78. PubMed ID: 16779669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obligatory intermolecular electron-transfer from FAD to FMN in dimeric P450BM-3.
    Kitazume T; Haines DC; Estabrook RW; Chen B; Peterson JA
    Biochemistry; 2007 Oct; 46(42):11892-901. PubMed ID: 17902705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemical and biological versatility of riboflavin.
    Massey V
    Biochem Soc Trans; 2000; 28(4):283-96. PubMed ID: 10961912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.